Increased thrombogenicity in patients with atherosclerosis of the peripheral arteries of the lower extremities: a case-control study.

Increased thrombogenicity in patients with atherosclerosis of the peripheral arteries of the lower extremities: a case-control study. - Changes in the coagulation in patients with peripheral arterial disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38884

Enrollment

Registered

2013-05-06

Start date

2013-11-18

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis Hypercoagulability peripheral arterial disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who have entered the PAD study, as PAD the novo with an EAI

Exclusion criteria

Exclusion criteria: - Patients with known coagulopathies (coagulation disorders) - Pregnancy - Chronic Inflammatory Disorders - Anti-phospholipid syndrome - Malignancies - Systemic anticoagulation (acenocoumarol, fenprocoumon, dabigatran, rivaroxaban)

Design outcomes

Primary

Measure	Time frame
1. Thrombogram* measurement in full-blood and PPP 2. Flow chamber assay 3. Thromboelastometry with added tPA 4. Measurement of Mi-RNA*s	—

Countries

Netherlands

Outcome results